S-CSP PVNPs elicited high titers of the CSP-specific antibody that binds CSPs on sporozoites of P. falciparum. Thus, S-CSP PVNPs, together with the S60-αTSR nanoparticle generated previously, should serve as good candidate vaccines against Plasmodium infection and malaria. Here, DNAJC5 is linked to malaria.